Search Results

Site Search

MayoComplete - Insights

Learn about our menu of MayoComplete testing including a 515-gene panel and multiple disease-specific panels, which span the cancer spectrum.

About Us - Insights

Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.

Neurology - Insights

A collaboration with Mayo Clinic BioPharma Diagnostics includes access to the neurologic disease testing capabilities of Mayo Clinic Laboratories. Our highly specialized neurology testing menu features more than 400 neurologist-backed...

The evolution of specimen accessioning and delivery - Insights

The last installment of our 50th Anniversary series explores how Mayo Clinic Laboratories pioneered best practices in the area of specimen accessioning and delivery.

A novel testing approach for newly identified VEXAS syndrome - Insights

VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...

Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody: Spencer Lodin - Insights

What started as a persistent headache for Spencer Lodin soon devolved into slowed speech, seizures, and hallucinations, symptoms which stumped ER doctors into thinking he had meningitis or was suffering from psychosis. Finally, specialized...

Synthesizing cardiovascular genetic test results into a unified diagnosis for the patient - Insights

For over two decades, Mayo Clinic has been at the forefront of cardiovascular (CV) genetic testing. The current test menu features 24 different panels that span over 300 genes linked to inherited cardiovascular disorders, many of which are...

Unveiling a novel hemoglobinopathy classification - Insights

In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine...

Hereditary testing by specialty - Insights

Mayo Clinic Laboratories is a one-stop laboratory for hereditary testing, featuring a robust menu of molecular, cytogenic, biochemical, and functional assays that support diagnosis and care.

Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights

It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...